FDA CDS Software Regulation
The Latest Guidance on Clinical Decision Support Software


Tuesday, April 7, 2020 • 1:30 p.m. - 3:00 p.m. EDT

NEW: The webinar will be updated to include FDA regulation of AI used to guide clinical management of the Coronavirus.


Does your software provide computerized alerts and reminders for providers and patients? Or clinical guidelines, condition-specific order set, focused patient data reports and summaries, documentation templates, diagnostic support or contextually relevant reference information?

If so, your clinical decision support (CDS) software might be regulated as a medical device.

You need to have a good grasp of the latest legal, regulatory and compliance nuances of FDA’s guidance on CDS software to be able to clarify the type of CDS software functions affected by legal developments like the 21st Century Cures Act.

Join FDAnews and legal expert Bradley Merrill Thompson for a comprehensive overview of current guidance on CDS software:

  • Master the legal, regulatory, and compliance nuances of the FDA’s guidance
  • Determine what types of CDS software functions do not meet the definition of a device as amended by the Cures Act
  • Assess which types of software meet the definition of a device for which the FDA may not enforce compliance under device requirements
  • Comprehend how the FDA intends to leverage the Software as a Medical Device: Possible Framework for Risk Categorization and Corresponding Considerations External Link Disclaimer (IMDRF Framework) in its risk-based approach to CDS regulation

Establish compliant best practices for your CDS software by understanding the legal, regulatory and compliance nuances of the FDA’s guidance. Join us by registering today.

Who Will Benefit

  • Medical device companies
  • Software manufacturers
  • Quality, regulatory, and compliance specialists at
    medical device companies
  • FDA attorneys
  • Consultants

Webinar plus USB Audio Recording/Transcript
Learn more

$487

add to cart

Webinar only
Learn more

$287

add to cart

24/7 Encore plus USB Audio Recording/Transcript
Learn more

$487

add to cart

24/7 Encore Presentation
Learn more

$287

add to cart

USB Audio Recording/Transcript
Learn more

$287

add to cart

 

Meet Your Presenter

Bradley Merrill Thompson

Shareholder
Epstein Becker & Green, P.C.

Your webinar leader is Bradley Merrill Thompson, a shareholder in the national law firm of Epstein Becker & Green, P.C., based out of the firm’s Washington, D.C. office. He counsels software, medical device, and drug companies on a wide range of FDA regulatory issues and leads the firm’s AI practice.

MII logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 703.538.7600 | Fax 703.538.7676 | Toll free 888.838.5578 | Email customerservice@fdanews.com

© 2020 FDAnews